Masashi Mizokami

36.3k total citations · 1 hit paper
489 papers, 21.8k citations indexed

About

Masashi Mizokami is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Masashi Mizokami has authored 489 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 379 papers in Hepatology, 371 papers in Epidemiology and 48 papers in Infectious Diseases. Recurrent topics in Masashi Mizokami's work include Hepatitis C virus research (359 papers), Hepatitis B Virus Studies (315 papers) and Liver Disease Diagnosis and Treatment (243 papers). Masashi Mizokami is often cited by papers focused on Hepatitis C virus research (359 papers), Hepatitis B Virus Studies (315 papers) and Liver Disease Diagnosis and Treatment (243 papers). Masashi Mizokami collaborates with scholars based in Japan, United States and China. Masashi Mizokami's co-authors include Yasuhito Tanaka, Etsuro Orito, Takanobu Kato, Takaji Wakita, Ryuzo Ueda, Tomoko Date, Michiko Miyamoto, Yuzo Miyakawa, Fuminaka Sugauchi and Masaya Sugiyama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Masashi Mizokami

476 papers receiving 21.2k citations

Hit Papers

Production of infectious ... 2005 2026 2012 2019 2005 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Mizokami Japan 73 16.3k 16.1k 2.6k 2.2k 1.5k 489 21.8k
Thomas Berg Germany 73 20.3k 1.2× 20.4k 1.3× 2.1k 0.8× 3.2k 1.5× 1.9k 1.3× 726 28.1k
Jean–Michel Pawlotsky France 82 19.7k 1.2× 17.6k 1.1× 2.4k 0.9× 3.5k 1.6× 719 0.5× 467 24.6k
Raymond T. Chung United States 79 13.5k 0.8× 12.9k 0.8× 3.7k 1.4× 2.6k 1.2× 1.9k 1.3× 431 23.1k
George Kuo Taiwan 54 15.3k 0.9× 14.1k 0.9× 2.7k 1.0× 1.6k 0.7× 649 0.4× 142 22.2k
David L. Thomas United States 72 21.7k 1.3× 21.0k 1.3× 1.2k 0.5× 4.2k 1.9× 873 0.6× 292 27.3k
Heiner Wedemeyer Germany 82 23.1k 1.4× 19.8k 1.2× 1.8k 0.7× 4.5k 2.1× 1.2k 0.8× 840 29.2k
Stuart C. Gordon United States 59 18.4k 1.1× 16.6k 1.0× 1.1k 0.4× 2.6k 1.2× 1.1k 0.7× 359 21.8k
Stanislas Pol France 71 15.1k 0.9× 14.2k 0.9× 925 0.4× 3.1k 1.4× 898 0.6× 484 18.9k
Eugene R. Schiff United States 78 22.8k 1.4× 22.5k 1.4× 1.3k 0.5× 3.2k 1.5× 2.7k 1.8× 372 28.9k
Francesco Negro Switzerland 64 12.4k 0.8× 12.2k 0.8× 1.4k 0.5× 1.5k 0.7× 823 0.6× 311 16.0k

Countries citing papers authored by Masashi Mizokami

Since Specialization
Citations

This map shows the geographic impact of Masashi Mizokami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Mizokami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Mizokami more than expected).

Fields of papers citing papers by Masashi Mizokami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Mizokami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Mizokami. The network helps show where Masashi Mizokami may publish in the future.

Co-authorship network of co-authors of Masashi Mizokami

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Mizokami. A scholar is included among the top collaborators of Masashi Mizokami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Mizokami. Masashi Mizokami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamanaka, Takahiro, Kenichiro Araki, Takehiko Yokobori, et al.. (2024). Potential of Mac‐2‐binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer Science. 115(4). 1241–1249. 7 indexed citations
2.
Akiyama, Shintaro, Suguru Nishijima, Yasushi Kojima, et al.. (2024). Multi-biome analysis identifies distinct gut microbial signatures and their crosstalk in ulcerative colitis and Crohn’s disease. Nature Communications. 15(1). 10291–10291. 14 indexed citations
3.
Jeng, Wen‐Juei, et al.. (2022). Serum HBcrAg and Hepatocellular Carcinoma in a Taiwanese Population Seronegative for HBsAg and Anti-HCV. Clinical Gastroenterology and Hepatology. 21(5). 1303–1313.e11. 6 indexed citations
4.
Imai, Shinobu, Hayato Yamana, Manabu Akazawa, et al.. (2019). Validity of administrative database detection of previously resolved hepatitis B virus in Japan. Journal of Medical Virology. 91(11). 1944–1948. 8 indexed citations
5.
Nishida, Nao, Masaya Sugiyama, Hiromi Sawai, et al.. (2018). Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology. 68(3). 848–858. 45 indexed citations
6.
Iwamoto, Masashi, Dawei Cai, Masaya Sugiyama, et al.. (2017). Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication. Scientific Reports. 7(1). 10620–10620. 41 indexed citations
7.
Masugi, Yohei, Tokiya Abe, Hanako Tsujikawa, et al.. (2017). Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatology Communications. 2(1). 58–68. 46 indexed citations
8.
Adachi, Eisuke, Masaya Sugiyama, Sayaka Shimizu, et al.. (2016). Human immunodeficiency virus and hepatitis B genotype G/A2 recombinant co-infection: a case study. SpringerPlus. 5(1). 1502–1502. 4 indexed citations
9.
Michikawa, Takehiro, Manami Inoue, Norie Sawada, et al.. (2014). Plasma Isoflavones and Risk of Primary Liver Cancer in Japanese Women and Men with Hepatitis Virus Infection: A Nested Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 24(3). 532–537. 14 indexed citations
10.
Aoki, Tomonori, Naoyoshi Nagata, Ryota Niikura, et al.. (2014). Recurrence and Mortality Among Patients Hospitalized for Acute Lower Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology. 13(3). 488–494.e1. 64 indexed citations
11.
Nishida, Nao, Katsushi Tokunaga, & Masashi Mizokami. (2013). Genome-Wide Association Study Reveals Host Genetic Factors for Liver Diseases. Journal of Clinical and Translational Hepatology. 1(1). 45–50. 5 indexed citations
12.
13.
Watanabe, Tsunamasa, Fuminaka Sugauchi, Yasuhito Tanaka, et al.. (2012). Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of theIL28Bgene. Gut. 62(9). 1340–1346. 18 indexed citations
14.
Aly, Hussein Hassan, Yue Qi, Kimie Atsuzawa, et al.. (2009). Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus #. Hepatology. 50(3). 689–696. 15 indexed citations
15.
Fujiwara, Kei, Yasuhito Tanaka, Etsuro Orito, et al.. (2004). Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus‐related chronic liver disease. Journal of Gastroenterology and Hepatology. 19(12). 1343–1347. 16 indexed citations
16.
Kurbanov, Fuat, Makiko Kondo, Yasuhito Tanaka, et al.. (2003). Human Immunodeficiency Virus in Uzbekistan: Epidemiological and Genetic Analyses. AIDS Research and Human Retroviruses. 19(9). 731–738. 39 indexed citations
17.
Sugauchi, Fuminaka, Etsuro Orito, Takafumi Ichida, et al.. (2003). Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 124(4). 925–932. 171 indexed citations
18.
Tanaka, Yasuhito, Takahisa Furuta, Seiji Suzuki, et al.. (2003). Impact of Interleukin‐1β Genetic Polymorphisms on the Development of Hepatitis C Virus–Related Hepatocellular Carcinoma in Japan. The Journal of Infectious Diseases. 187(11). 1822–1825. 47 indexed citations
19.
Lau, Johnson Y. N., Keping Qian, Jill Detmer, et al.. (1997). Effect of Interferoh α and Ribavirin Therapy on Serum GB Virus C/Hepatiti G Virus (GBV‐C/HGV) RNA Levels in Patients Chronical Infected with Hepatitis C Virus and GBV‐C/HGV. The Journal of Infectious Diseases. 176(2). 421–426. 22 indexed citations
20.
Ishiguro, Hiroshi, Iwao Ohkubo, Masashi Mizokami, Koiti Titani, & Makoto Sasaki. (1989). The Use of Monoclonal Antibodies to Define Levels of Cystatin C in Normal Human Serum. Hybridoma. 8(3). 303–313. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026